Venture continues to woo investors

While buyout giants lick their wounds (or begin religiously popping Arnica to ward off imminent pain and suffering), the venture world is convincing investors that it is the place to be.

This issue features two venture fund closes, both impressive for their size as well as the swiftness of their raising. Accel Partners closed its third European and Israeli venture fund on $525m after just two months on the road.

Separately, Abingworth raised an additional £84m for its Bioventures V LP, bringing the total to £392m. The extra funds were raised in a parallel vehicle, Abingworth Bioventures V Co-Invest Growth Equity Fund.

The top-up from existing investors stands in marked contrast to the scaling back other buyout chiefs are doing (Permira; see Moulton comment on page 8) and thinking of doing.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Industry
• UK / Ireland